1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Multiple Doses of Anti-SARS-CoV-2 convalescent plasma: new trials by email Literature Review of Multiple Doses of Anti-SARS-CoV-2 convalescent plasma trials Research Report on Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure Multiple Doses of Anti-SARS-CoV-2 convalescent plasma - Covid-19, Sars-CoV2 | Early Phase 1 | Terminated | Noah Merin | 6 | 2020-06-27 | 2021-11-08 |
| Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19 Multiple doses of anti-SARS-CoV-2 Convalescent Plasma - COVID-19 | Early Phase 1 | Completed | Hospital Regional Dr. Rafael Estévez | 30 | 2020-06-06 | 2022-10-27 |
COVID-19 (2) · Critical Illness (1)
Hospital Regional Dr. Rafael Estévez (1) · Noah Merin (1)
Panama (1) · United States (1)
David Hager, MD PhD (1) · Noah Merin, MD PhD (1) · Ricardo Aguilar, M.D (1)